In her new role, Alison will be responsible for both the commercial and communications functions at the ABPI, and for co-ordinating the work of the ABPI’s four work streams around Value, Innovation, Trust and Access (VITA).
Richard Barker, Director General said: “This move will help to ensure greater synergy across the imperatives and ensure there is coherent communication of the very real progress we are making.”
“A great deal of effort has gone into the VITA work streams since they were started last year and a huge amount has been achieved, from the Prime Minister’s summit to the Office for Life Sciences Blueprint to the Patent Box & the Innovation Pass.
“Part of this new role will be to ensure all of our different stakeholders, especially our members, are aware of the number of things we are doing on behalf of industry.”
Alison moves into the new role following the departure of David Lewis, Director of Corporate Affairs, and David Fisher, Commercial Director, from the ABPI last month.
Alison joined the ABPI in May from Innovex where she held a series of top management roles, including running their UK business. Before Innovex, she had a variety of roles during 15 years at GlaxoSmithKline. Alison, a pharmacist by training, officially took up her new role on January 4.
For further information, please contact the ABPI press office: 020 7747 1410.
Notes to Editors:
A picture of Alison Clough is available.